Markets:

Overview

News

Currencies

International

Treasuries

Reckitt Benckiser Group Plc (OP:RBGPF)

67.19 -3.54 (-5.01%)

Streaming Delayed Price Updated: 1:25 PM EDT, Apr 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Reckitt Benckiser Group Plc

FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns ↗

November 08, 2024

FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued.

Via Benzinga

Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula ↗

September 18, 2024

Reckitt Benckiser is reportedly in early talks to sell its homecare division, featuring brands like Air Wick and Calgon, as part of a broader strategy to focus on consumer health and hygiene. The sale...

Via Benzinga

Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits ↗

July 08, 2024

Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial among hundreds of similar lawsuits, impacting Abbott and Reckitt...

Via Benzinga

Topics Lawsuit

What's Going On With Abbott Laboratories Stock On Friday? ↗

March 15, 2024

An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about...

Via Benzinga

Topics Lawsuit

Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online ↗

February 29, 2024

Reckitt Benckiser Group is leveraging the popularity of livestream shopping in China to sell condoms, a move that could be challenging due to strict regulatory oversight.

Via Benzinga

British Consumer Company Reckitt Benckiser's CEO Steps Down ↗

September 01, 2022

Via Benzinga

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch ↗

September 12, 2023

According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...

Via Benzinga

Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process ↗

May 24, 2023

Via Benzinga

Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report ↗

December 02, 2022

Via Benzinga

Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report ↗

August 11, 2022

Via Benzinga

Reckitt Lifts Annual Forecast On Higher Prices, Baby Formula Shortage ↗

July 27, 2022

Via Benzinga

More Companies Join Race To Ease US Baby Formula Supply Crunch ↗

May 25, 2022

Danone SA (OTC: DANOY) has been doubling shipments to the U.S. of Neocate formula for infants allergic to cow's milk, while Enfamil maker Reckitt is also working to boost supplies amid a nationwide...

Via Benzinga

Danone Scales Up Baby Formula Shipments To US To Combat Shortage: Reuters ↗

May 20, 2022

Danone SA (OTC: DANOY) has stepped u

Via Benzinga

Morning Brief: Top Financial Stories Dominating on Friday, April 29 ↗

April 29, 2022

CNBC Hertz Chief Sees Business Travel Recovery Choking Already Strained Used Car Supply Hertz Global Holdings, Inc (NASDAQ: HTZ) chief Stephen Scherr saw a recovery in business...

Via Benzinga

Reckitt Benckiser Hikes Prices To Compensate For Falling Demand: FT ↗

April 29, 2022

Reckitt Benckiser Group Plc (OTC: RBGLY) (OTC: RBGPF) has hiked prices across its product range to pass an increase in raw material costs onto customers, the Financial...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.